| Health-related quality of life and patient-centred outcomes with olaparib maintenance after chemotherapy in patients with platinum-sensitive, relapsed ovarian cancer and a … M Friedlander, V Gebski, E Gibbs, L Davies, R Bloomfield, F Hilpert, ... The Lancet Oncology 19 (8), 1126-1134, 2018 | 146 | 2018 |
| D-dimer predicts long-term cause-specific mortality, cardiovascular events, and cancer in patients with stable coronary heart disease: LIPID study J Simes, KP Robledo, HD White, D Espinoza, RA Stewart, DR Sullivan, ... Circulation 138 (7), 712-723, 2018 | 132 | 2018 |
| Interventions commenced by early infancy to prevent childhood obesity—the EPOCH collaboration: an individual participant data prospective meta‐analysis of four randomized … LM Askie, D Espinoza, A Martin, LA Daniels, S Mihrshahi, R Taylor, ... Pediatric Obesity 15 (6), e12618, 2020 | 60 | 2020 |
| Immediate delivery compared with expectant management in late preterm prelabor rupture of membranes: an individual participant data meta-analysis J Quist-Nelson, AA De Ruigh, AL Seidler, DP Van Der Ham, C Willekes, ... Obstetrics & Gynecology 131 (2), 269-279, 2018 | 57 | 2018 |
| A pilot randomized controlled trial of the feasibility, acceptability, and impact of giving information on personalized genomic risk of melanoma to the public AK Smit, D Espinoza, AJ Newson, RL Morton, G Fenton, L Freeman, ... Cancer Epidemiology, Biomarkers & Prevention 26 (2), 212-221, 2017 | 52 | 2017 |
| Sentinel-lymph-node-based management or routine axillary clearance? Five-year outcomes of the RACS sentinel node biopsy versus axillary clearance (SNAC) 1 trial: assessment and … N Wetzig, PG Gill, D Espinoza, R Mister, MR Stockler, VJ Gebski, OA Ung, ... Annals of surgical oncology 24, 1064-1070, 2017 | 45 | 2017 |
| Constipation and other common symptoms reported by women and men in methadone and buprenorphine maintenance treatment PS Haber, M Elsayed, D Espinoza, N Lintzeris, AS Veillard, R Hallinan Drug and Alcohol Dependence 181, 132-139, 2017 | 44 | 2017 |
| Changes in body weight and blood pressure: paradoxical outcome events in overweight and obese subjects with cardiovascular disease RV Seimon, D Espinoza, L Ivers, V Gebski, N Finer, UF Legler, ... International Journal of Obesity 38 (9), 1165-1171, 2014 | 42 | 2014 |
| A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO … A Davidson, AS Veillard, A Tognela, MMK Chan, BGM Hughes, M Boyer, ... Annals of Oncology 26 (11), 2280-2286, 2015 | 38 | 2015 |
| Impact of personal genomic risk information on melanoma prevention behaviors and psychological outcomes: a randomized controlled trial AK Smit, M Allen, B Beswick, P Butow, H Dawkins, SJ Dobbinson, ... Genetics in Medicine 23 (12), 2394-2403, 2021 | 29 | 2021 |
| Assessing the potential for patient-led surveillance after treatment of localized melanoma (MEL-SELF): a pilot randomized clinical trial DM Ackermann, M Dieng, E Medcalf, MC Jenkins, CH Van Kemenade, ... JAMA dermatology 158 (1), 33-42, 2022 | 28 | 2022 |
| Does personalized melanoma genomic risk information trigger conversations about skin cancer prevention and skin examination with family, friends and health professionals? AK Smit, LA Keogh, AJ Newson, PN Butow, K Dunlop, RL Morton, J Kirk, ... British Journal of Dermatology 177 (3), 779-790, 2017 | 26 | 2017 |
| Transforming Obesity Prevention for CHILDren (TOPCHILD) Collaboration: protocol for a systematic review with individual participant data meta-analysis of behavioural … KE Hunter, BJ Johnson, L Askie, RK Golley, LA Baur, IC Marschner, ... BMJ open 12 (1), e048166, 2022 | 22 | 2022 |
| Insomnia and excessive daytime sleepiness in women and men receiving methadone and buprenorphine maintenance treatment R Hallinan, M Elsayed, D Espinoza, AS Veillard, KC Morley, N Lintzeris, ... Substance Use & Misuse 54 (10), 1589-1598, 2019 | 20 | 2019 |
| A systematic review and meta‐analysis of utility estimates in melanoma AD Tran, G Fogarty, AK Nowak, D Espinoza, N Rowbotham, MR Stockler, ... British Journal of Dermatology 178 (2), 384-393, 2018 | 20 | 2018 |
| REZOLVE (ANZGOG-1101): A phase 2 trial of intraperitoneal bevacizumab to treat symptomatic ascites in patients with chemotherapy-resistant, epithelial ovarian cancer KM Sjoquist, D Espinoza, L Mileshkin, S Ananda, C Shannon, S Yip, ... Gynecologic Oncology 161 (2), 374-381, 2021 | 19 | 2021 |
| Health-related quality of life outcomes from CABARET: a randomized phase 2 trial of carboplatin and bevacizumab in recurrent glioblastoma KM Field, MT King, J Simes, D Espinoza, EH Barnes, K Sawkins, ... Journal of Neuro-oncology 133, 623-631, 2017 | 19 | 2017 |
| SPAR–a randomised, placebo-controlled phase II trial of simvastatin in addition to standard chemotherapy and radiation in preoperative treatment for rectal cancer: an AGITG … MB Jameson, K Gormly, D Espinoza, W Hague, G Asghari, GM Jeffery, ... BMC cancer 19, 1-12, 2019 | 18 | 2019 |
| Unpacking the behavioural components and delivery features of early childhood obesity prevention interventions in the TOPCHILD Collaboration: a systematic review and … BJ Johnson, KE Hunter, RK Golley, P Chadwick, A Barba, M Aberoumand, ... BMJ open 12 (1), e048165, 2022 | 16 | 2022 |
| Knowledge, views and expectations for cancer polygenic risk testing in clinical practice: A cross‐sectional survey of health professionals AK Smit, AR Sharman, D Espinoza, C Wallingford, MA Young, K Dunlop, ... Clinical Genetics 100 (4), 430-439, 2021 | 16 | 2021 |
